Skip to main content
Glama

Blockstream Info

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only, idempotent, open-world annotations, the description reveals important behaviors: graceful degradation if GLEIF/OpenFIGI is unavailable, returning figi_candidates when ambiguity arises, marking unresolved identifiers explicitly, and labelling every identifier with its source. This gives an agent an accurate mental model of the tool's behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and information-dense, but it is front-loaded with the purpose and 'USE FIRST' directive, and each paragraph covers a different aspect (supported types, behavior, parameter semantics). Some redundancy exists (e.g., repeating identifier types), so it isn't perfectly concise, but nothing is filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return behavior: it explicitly mentions figi_candidates, unresolved fields, source labels, and fallback behavior when enrichment services are unavailable. Combined with the detailed parameter guidance, an agent has everything needed to call and interpret the tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though the input schema already documents both parameters, the description adds crucial semantics: 'Pass the ENTITY NAME ONLY', example values (AAPL, 0000320193), and a concrete warning that trailing security-class words will make a bond lookup fail. This goes well beyond the schema's coverage, which is 100%.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries and states the core purpose: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It names the exact action (resolve), the resource (names to identifiers), and enumerates supported types (company, drug), clearly differentiating it from sibling tools like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID' and explains that it replaces 2-3 manual lookups. It doesn't explicitly name alternatives for when-not-to-use, but the 'use FIRST' directive is strong and the supported-type breakdown clarifies scope.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Blockstream Info toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.1/5.0
Disambiguation1/5

The tool set includes multiple near-identical tools (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) and several overlapping entity/profile tools (entity_profile, compare_entities, resolve_entity, validate_claim) that make it hard for an agent to choose the right one. The Bitcoin-specific tools are isolated and don't integrate well with the rest, creating two separate domains.

Naming Consistency2/5

Naming conventions are mixed: some tools use snake_case (ask_pipeworx, fee_estimates), some use underscores (polymarket_edges), and others are standalone verbs (remember, recall, forget). No consistent pattern is followed across the tool set.

Tool Count2/5

With 39 tools, the server is overstuffed for its stated purpose ('Blockstream Info'). The Bitcoin blockchain tools are only 7, while the rest are a sprawling external data platform (Pipeworx) with many redundant tools, making the number feel excessive and unfocused.

Completeness2/5

For a Bitcoin-oriented server, the blockchain tools cover basic operations (address, block, transaction, fee_estimates) but miss essentials like UTXO queries or block details. Meanwhile, the Pipeworx tools dominate and are overcomplete for a server that should be lightweight. The mismatch leaves the Bitcoin part incomplete.

Resources